title: Mycobacterial osteomyelitis and arthritis.
abstract: Physicians can expect to see more mycobacterial bone and joint disease in North America as a result of increased travel, immigration, and use of immunosuppressive medications. The first step in treating infections caused by these organisms is to consider the diagnosis early in the course of illness. Long-standing untreated mycobacterial infections typically cause significant bone destruction and loss of function. The treatment of mycobacterial bone and joint infection requires prolonged antibiotic therapy, often in conjunction with surgical intervention, particularly for spinal tuberculosis.
authors.affiliation: Tuberculosis Clinic, Toronto Western Hospital, Toronto, ON, Canada. michael.gardam@uhn.on.ca
authors.forename: Michael
authors.initials: M
authors.lastname: Gardam
authors.forename: Sue
authors.initials: S
authors.lastname: Lim
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D006801:Humans; D010019:Osteomyelitis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D014394:Tuberculosis, Osteoarticular / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology
chemical_list: D000305:Adrenal Cortex Hormones; D000995:Antitubercular Agents